iCAD, Inc. (ICAD) and Invivo Corporation Announce Global Strategic Agreement to Deliver MRI Solutions Worldwide
3/11/2013 10:58:38 AM
GAINESVILLE, Fla. & NASHUA, N.H.--(BUSINESS WIRE)--Invivo, a Philips Healthcare Business, and a worldwide leader in MRI, and iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer, today announced that the companies have entered into a global research, development, and commercial agreement. Under the agreement, iCAD will develop advanced MRI image analysis software products which Invivo will incorporate into its suite of MRI product solutions for global commercial sale. The first products are anticipated to be available in Q2 2013. The initial focus of the partnership will be the release of a next generation platform for prostate and breast imaging. Additional new product releases are also anticipated beginning the second half of 2013.
comments powered by